Establishing Cardiovascular Biomarkers to Define Preferred Lantus® Use

Clinical trial NCT01500850 · UNKNOWN

Trial details

NCT number: NCT01500850
Sponsor: ikfe-CRO GmbH
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Insulin-requiring Type 2 Diabetes Mellitus

Start date: 2011-10-01
Primary completion: 2012-10-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.